peptide name for tirzepatide Compounded Tirzepatide: A Dual-Action Tirzepatide (GLP-1/GIP) - 15mg -
Description
Tirzepatide is designed for weekly dosing based on its five-day half-life

Kortepeter, Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration, JAMA Intern
Advise patients to refer to the IFU in case of any change in the presentation

Some particles may be peptide aggregates

There have been reports of people accidentally taking a much larger dose than intended of compounded semaglutide or tirzepatide, leading to side effects like nausea, vomiting, and diarrhea sometimes so severe that they required hospitalization

Semaglutide Has been around longer, so there may be more coverage options
